(Q33217628)

English

Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

1 reference

based on heuristic

inferred from title

object named as

Roberta Bulla

3

0 references

object named as

Paolo Macor

2

0 references

author name string

Federica Ziller

1

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Daniele Sblattero

4

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Roberto Marzari

5

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Francesco Tedesco

6

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

2175-2183

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

Mannose-binding protein recognizes glioma cells: in vitro analysis of complement activation on glioma cells via the lectin pathway.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

21 January 2018

Complement activation determines the therapeutic activity of rituximab in vivo.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

21 January 2018

Structural correlates of an anticarcinoma antibody: identification of specificity-determining residues (SDRs) and development of a minimally immunogenic antibody variant by retention of SDRs only

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

21 January 2018

Complement. Second of two parts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis of C3, C5, C6, C7, C8, and C9 by human fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

The endothelium is an extrahepatic site of synthesis of the seventh component of the complement system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Activation of the alternative complement pathway by lymphoblastoid cell lines derived from patients with Burkitt's lymphoma and infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Complement function in mAb-mediated cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploiting recombination in single bacteria to make large phage antibody libraries

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Mammalian cell expression of dimeric small immune proteins (SIP).

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

The regulators of complement activation (RCA) gene cluster

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Generating improved single-chain Fv molecules for tumor targeting

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of single-chain Fv-Fc fusions in Pichia pastoris

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Decline of surface MHC I by adenoviral gene transfer of anti-MHC I intrabodies in human endothelial cells-new perspectives for the generation of universal donor cells for tissue transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrabody-based strategies for inhibition of vascular endothelial growth factor receptor-2: effects on apoptosis, cell growth, and angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

The cleavage site of C5 from man and animals as a common target for neutralizing human monoclonal antibodies: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

A definitive set of oligonucleotide primers for amplifying human V regions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Construction of solid matrix-antibody-antigen complexes containing simian immunodeficiency virus p27 using tag-specific monoclonal antibody and tag-linked antigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracerebroventricular injection of the terminal complement complex causes inflammatory reaction in the rat brain

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200425920

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.200425920

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33217628&oldid=1537233279"